Based on this consensus, in 2024, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule to establish treatment of obesity as a medically necessary service under Medicare and Medicaid, paving the way for covering weight loss drug under these programs in the future
They are usually solitary but can be multiple
If you are pregnant, planning pregnancy, or breastfeeding, speak to your GP immediately about safe alternatives for managing weight and metabolic health that prioritise both maternal and foetal wellbeing
Galsgaard KD, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ
Researchers most commonly select 20mg for: Single-arm pilot studies baseline characterisation of triple-agonist activity in a chosen cell or tissue model Receptor binding assays GLP-1R, GIPR, and glucagon receptor displacement work where modest substrate quantities suffice Comparative studies when R3TA is benchmarked head-to-head against single- or dual-receptor agonists (semaglutide, tirzepatide) in matched assays Short in-vitro time-courses 12 week protocols where 20mg covers full study consumption without surplus For dose-response curves, extended multi-arm studies, or higher-throughput assay panels, the R3TA 30mg preparation is the more cost-effective and protocol-appropriate size